HIGHLIGHTS: Emma Walmsley - CEO of GSK
In Good Company with Nicolai Tangen
Innovative Synergies in Vaccines and Medicines
This chapter explores the complementary relationship between vaccines and medicines, focusing on the role of vaccines in disease prevention. It also discusses the impact of technology and AI on clinical trials, predicting a future shift towards a more integrated, patient-centered model in pharmaceutical development.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
